Back to search
Rectal Cancer Recurrent
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Rectal Cancer Recurrent trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Rectal Cancer Recurrent trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This clinical trial compares minimal residual disease (MRD) testing with the Haystack blood test (assay) to the Signatera® assay for the early detection of the…
This is a study to evaluate the safety and preliminary anti-tumor activity of STRO-004 in adults with metastatic cancer. This study includes 3 parts: * Part 1A…
This study is designed to assess the efficacy and safety of ifinatamab deruxtecan (I-DXD) in the following tumor types: endometrial cancer (EC); head and neck s…
DNA methylation changes occur early and broadly during carcinogenesis. Methylscape is a rapid assay that detects global DNA methylation patterns in body fluids…
The purpose of this study is to compare how long the participants are disease-free (progression-free survival) and and the length of time until a participant di…
The optimal curative-intent management of locally recurrent rectal cancer (LRRC) typically involves multimodality therapy, comprising neoadjuvant therapy and su…
This phase II trial studies how well time-restricted eating works in reducing side effects of radiation or chemoradiation side effects when compared to nutritio…
The goal of this study is to learn how the treatment given to patients with recurrent rectal cancer affects their well being and quality of life.